Bausch Health Companies Inc. (BHC) — research page
US · us-cm-kg/NYSE/BHC · as of 2026-11-08
Identity and listing
The issuer is Bausch Health Companies Inc., listed on the NYSE under ticker BHC. Its ISIN is US0717341079. Its LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-NJ). Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, New Jersey. Its segment is not on the record. Its status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Bausch Health Companies Inc. | source · 2026-11-08 |
| exchange | NYSE | source · 2026-11-08 |
| ticker | BHC | source · 2026-11-08 |
| ISIN | US0717341079 | source · 2026-10-08 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — New Jersey | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 67 filings in the twelve months to 2026-11-08, across 36 filing days. The median gap between filing days is 6 days. The latest filing is dated 2026-10-29 and is of type results, 10 days before the record date. The NYSE median is 6.0 days of cadence gap, 64.0 filings and 4.0 days of latency across 3256 issuers. The 2834 Pharmaceutical Preparations sector median is 6.0 days of cadence gap, 63.0 filings and 4.0 days of latency across 526 issuers. The filings by type are: 38 directors' dealings, 9 results, 8 regulatory filings, 7 corporate news, 3 AGM/EGM and 2 director changes.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 67 | 6 | 10 |
| exchange median: NYSE (3256 issuers) | 64 | 6 | 4 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-29 | results | 10-Q | 10-Q — 10-Q |
| 2026-10-28 | results | 8-K | 8-K — 8-K (items 2.02,9.01) |
| 2026-10-02 | directors_dealings | 4 | 4 — PRIMARY DOCUMENT |
| 2026-10-02 | directors_dealings | 4 | 4 — PRIMARY DOCUMENT |
| 2026-10-02 | directors_dealings | 4 | 4 — PRIMARY DOCUMENT |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). Its location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change events. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's own investor-relations page names 6 research houses: Barclays, Evercore ISI, Jefferies, Raymond James, RBC Capital Markets and TD Cowen.
| research house | analyst | source · read date |
|---|---|---|
| Barclays | Glen Santangelo | issuer page · 2026-11-11 |
| Evercore ISI | Umer Raffat | issuer page · 2026-11-11 |
| Jefferies | Young Li | issuer page · 2026-11-11 |
| Raymond James | Michael Freeman | issuer page · 2026-11-11 |
| RBC Capital Markets | Douglas Miehm | issuer page · 2026-11-11 |
| TD Cowen | Michael Nedelcovych | issuer page · 2026-11-11 |
Open research
No openly published research notes were found. The record holds none.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage is sealed. The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0000885590.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NYSE/BHC (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://www.ir.bauschhealth.com/stock-information/analyst-coverage (coverage)
- 10.8
- https://mcp.us-cm-kg.ai/record/NYSE/BHC (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US0717341079"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:1b495f39be6e5ad5.